Log in to search using one of your social media accounts:

Hormone Therapy Not Advised for Preventing Disease After Menopause

Benefits of treatment don't outweigh the risks, U.S. task force reiterates Source: HealthDay Related MedlinePlus Pages: Hormone Replacement Therapy
Source: MedlinePlus Health News - Category: Consumer Health News Source Type: news

Related Links:

Doctors have been adding a new tool to the arsenal of how they restore the sex lives of menopausal and post-menopausal women: the humble vibrator. With the onset of menopause, a decrease in the production of hormones causes vaginal tissue to get thinner and drier. Vaginal muscles can also atrophy, leading to painful sex ― a problem for half of all menopausal and post-menopausal women, according to the National Institutes of Health. But the solution might be as simple as a vibrating piece of silicon.  Vibrators that are used internally stimulate pelvic blood flow, which increases vaginal mois...
Source: Healthy Living - The Huffington Post - Category: Consumer Health News Source Type: news
Throughout decades of study, hormone therapy (HT), often but not always the same as hormone replacement therapy (HRT), has been glorified and demonized in turn. The information that doctors receive has come from ongoing studies that seemed to offer over time radically conflicting results. A new study may add more confusion since this study has found that not only does HT given near menopause create changes in a woman’s brain, but motherhood itself creates changes. Read full article on how changing hormones can alter the risk of Alzheimer's: Support a caregiver or jump start discussion in support groups with real stor...
Source: Minding Our Elders - Category: Geriatrics Authors: Source Type: blogs
A new study, published inMenopause,examines the link between menopausal age, the use of oral hormonal therapy, and hearing loss.Medical News Today
Source: Society for Endocrinology - Category: Endocrinology Source Type: news
(Cedars-Sinai Medical Center) Hormone replacement therapy has long been controversial as studies have associated it with health benefits and risks. While some studies suggest that it lowers the risk of osteoporosis and improves some aspects of heart health, others link it to higher risk of cancer and stroke. Now, a new imaging study suggests that women using hormone replacement therapy to relieve menopause symptoms face a lower risk of death and show lower levels of atherosclerosis compared to women who do not use hormone therapy.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news
Drospirenone (DRSP) is an antialdosterone agent with progestogenic and antiandrogenic effects. This compound, has been recently used in combination with 17 ß-estradiol (E2) as hormonal therapy in postmenopausal women and has been shown to exert a significant antihypertensive effect in hypertensive post-menopausal women. Aim of the present study was to compare the effect of DRSP/E2 with those of Tibolone (T) on endothelial function, arterial stiffness, and lipid profile of early postmenopausal women naïve on post-menopausal hormonal therapy.Twenty-four women met the inclusion criteria and entered the study.
Source: International Journal of Cardiology - Category: Cardiology Authors: Source Type: research
Many women who are going through menopause (see page e102, "About menopause") have symptoms (e.g., "hot flashes") that may be difficult. Some women choose to treat these symptoms through hormone replacement therapy. Hormones may include estrogen and progesterone.
Source: Neurology - Category: Neurology Authors: Tags: PATIENT PAGES Source Type: research
Risk of breast cancer in women taking combined menopausal hormone therapy is three times higher than in non-users, study finds.
Source: The Pharmaceutical Journal - Category: Drugs & Pharmacology Source Type: research
Conclusion This study shows a link between the use of combined oestrogen and progesterone HRT and breast cancer risk, particularly among women who take the pill for a long period of time. But this is not the entire story. The study included a large cohort of women. The risk increase for combined HRT is based on only 52 of the 39,183 women taking the combined pill who developed breast cancer. Of these, only seven women had been taking the pill for more than 15 years. Therefore, the analysis was based on a very small number, which may mean the risk associations are not completely accurate....
Source: NHS News Feed - Category: Consumer Health News Tags: Cancer Medication Older people Source Type: news
5-year study found no difference in thinking skills, with or without estrogen treatment Source: HealthDay Related MedlinePlus Pages: Hormone Replacement Therapy, Memory, Menopause
Source: MedlinePlus Health News - Category: Consumer Health News Source Type: news
5-year study found no difference in thinking skills, with or without estrogen treatment Source: HealthDay Related MedlinePlus Pages: Hormone Replacement Therapy, Memory, Menopause
Source: MedlinePlus Health News - Category: Consumer Health News Source Type: news
More News: Health | Hormonal Therapy | Hormone Replacement Therapy | Hormones | Men | Menopause